| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/26/2004 | WO2003057014A9 Biomarkers for detecting ovarian cancer |
| 02/26/2004 | WO2003055975A3 A method for engineering strand-specific, sequence-specific, dna-nicking enzymes |
| 02/26/2004 | WO2003054140A9 Phosphate limited inducible promoter and a bacillus expression system |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003046568A3 Protein biopolymer markers indicative of a disease state |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003029495A3 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003020899A3 Compositions and methods relating to lung specific genes and proteins |
| 02/26/2004 | WO2003016472A9 Hybrid interferon/interferon tau proteins, compositions and methods of use |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2002083937A3 Methods using o6-alkylguanine-dna alkyltransferases |
| 02/26/2004 | WO2002083890A3 Use of clya hemolysin for excretion of fusion proteins |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002074808A3 Modified insulin with reduced immunogenicity |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002042336A3 Fgf-affinity chromatography |
| 02/26/2004 | WO2001074299A3 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 02/26/2004 | US20040040062 Method for producing human lactoferrin in plant cell culture |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039184 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 02/26/2004 | US20040039178 Metal chelate-labelled peptides |
| 02/26/2004 | US20040039168 Staged assembly process for nanometer-sized peptide structures useful in construction of microscopic and macroscopic structures; sequentially adding individual building blocks to growing structure to build nanostructure |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040039162 Gdf-1 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038430 Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 02/26/2004 | US20040038394 Expression vector using for animal cell |
| 02/26/2004 | US20040038381 Comprises genetically engineered strains of Pichia; mannosidases; glycoproteins; kits |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038358 Contains a ubiquitin pathway protein binding moiety which recognizes a ubiquitin pathway protein and a targeting moiety which recognizes a target protein |
| 02/26/2004 | US20040038349 Heteromultimeric TNF ligand family members |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038331 Solid phase synthesis of biomolecule conjugates |
| 02/26/2004 | US20040038319 Labeled diagnostic reagent for use in quanitative proteomics and diagnosing muscular dystrophy |
| 02/26/2004 | US20040038314 Immunoglobulin for diagnosis and treatment of oligospermia |
| 02/26/2004 | US20040038308 Hybrid antibodies |
| 02/26/2004 | US20040038291 Comprises immunoglobulin polypeptide library for diagnosis, prevention, suppression and/or treatment of inflammatory, cancer, viral, autoimmune and arthritic diseases |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038257 Therapeutic peptidase for diagnosis, treatment and prevention of cancer and nervous system disorders |
| 02/26/2004 | US20040038237 Pichia pastoris formate dehydrogenase and uses therefor |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040037833 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040037823 Epidermal growth factors (ErbB2); comprises doxorubicin; gene expression inhibition; anticancer agents |
| 02/26/2004 | US20040037821 For expression of erythropoietin; genetic translocation; zinc finger motifs |
| 02/26/2004 | US20040037805 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of |
| 02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | CA2496437A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | CA2496029A1 Carbohydrate library constructed by gene alteration of cargo receptors |
| 02/26/2004 | CA2495177A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | CA2492524A1 Humanized rabbit antibodies |
| 02/25/2004 | EP1391518A1 Process for producing peptide |
| 02/25/2004 | EP1391517A1 Process for producing glutathione |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391511A1 Artificial human chromosome containing human antibody lambda light chain gene |
| 02/25/2004 | EP1391510A1 Method of constructing host and process for producing foreign protein |
| 02/25/2004 | EP1391464A1 Anti-cd40 monoclonal antibody |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390511A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| 02/25/2004 | EP1390507A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 02/25/2004 | EP1390506A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390503A2 Novel nucleic acid molecules |
| 02/25/2004 | EP1390497A2 Human cdnas and proteins and uses thereof |
| 02/25/2004 | EP1390496A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 02/25/2004 | EP1390483A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 02/25/2004 | EP1390478A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390409A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 02/25/2004 | EP1390404A2 Interleukin-1 related gene and protein |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390389A2 Cripto blocking antibodies and uses thereof |
| 02/25/2004 | EP1390064A2 Method of treating malignancies through induction of blood immune responses |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0820515B1 Phospholipase c homolog |
| 02/25/2004 | EP0759987B1 Antibody against human restrictin |
| 02/25/2004 | EP0749478B1 Yeast strains and modified albumins |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN2604440Y Arrangement for producing high-absorbance rhodophyll with ceylon sea membrance |
| 02/25/2004 | CN1477969A Chemokine mutants in treatment of multiple sclerosis |